Amneal Seeks Approval of IPX-203 in US to Boost Patient ‘Good On’ Time
Amneal Pharmaceuticals is seeking U.S. approval of IPX-203, its extended-release carbidopa-levodopa (CD/LD) tablets, for Parkinson’s disease. The company…
Articles by Patricia Inácio, PhD
Potential of Vaccines in Treating Parkinson’s, Alzheimer’s Detailed
In a webinar hosted by AC Immune, scientists discussed the various advantages of vaccines — ranging from their…
Oxford Parkinson’s Center Partners to Spot Key Progression Biomarkers
The University of Oxford Parkinson’s Disease Centre is working with Metabolon to identify metabolic biomarkers of Parkinson’s risk…
Parkinson’s Foundation Awards 33 Grants Worth $5.7M
Note: This story was updated Aug. 18, 2022, to reflect researchers awarded The Stanley Fahn Junior Faculty Award will receive…
Yale Scientists Will Use $9M Grant to Create Map of Gut-brain Axis
Researchers at Yale School of Medicine will use a $9 million grant to generate a detailed map of the “gut-brain…
Older Age, Low Physical Activity Linked with Faster Motor Decline
An older age at diagnosis, but also reduced physical activity due to medical or social conditions, were significantly linked with…
Koneksa Wins MJFF Grant to Investigate Digital Biomarkers
Koneksa has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to investigate…
Case Suggests Toxic Clumps of TDP-43 Protein as Cause of Parkinson’s
The accumulation of toxic clumps of the protein TDP-43 — rather than alpha-synuclein protein, considered the hallmark of Parkinson’s…
NfL Blood Test May Help Diagnose Neurodegenerative Diseases
Labcorp has launched a test to detect the presence of a protein called neurofilament light chain (NfL) in the…
MJFF Supports Work on RRx-001, Targeting Neuroinflammation
A $500,000 grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to EpicentRx will support continuing work into the…